← All companies
JAGX
Jaguar Health, Inc.
$1.00
-0.04 -3.85%
Key statistics
from XBRL data in SEC filingsMarket cap
$516K
Revenue (TTM)
$29.6M
Net income (TTM)
$19.1M
EPS (TTM)
$547.88
P/E ratio
0.0
Dividend yield
—
Free cash flow
-$23.7M
Cash
$7.28M
Total assets
$37.4M
Gross margin
—
52-week range
$0.91 – $92.75
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement
Jul 14, 2026
8-K
Other events
Jul 1, 2026
8-K
Entered a material agreement; Other events
Jun 25, 2026
8-K/A
Regulation FD disclosure
Jun 22, 2026
8-K
Regulation FD disclosure
Jun 22, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jun 18, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws
Jun 11, 2026
8-K
Shareholder vote results; Regulation FD disclosure
Jun 8, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jun 2, 2026
8-K
Regulation FD disclosure; Other events
May 27, 2026
8-K
Entered a material agreement; Other events
May 22, 2026
8-K
Results of operations (earnings release)
May 20, 2026
10-Q
Quarter ended 2026-03-31
May 20, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Amended charter or bylaws
May 19, 2026
8-K
Other events
May 7, 2026
8-K
Other events
May 4, 2026
8-K
Delisting notice or listing-rule failure
May 4, 2026
8-K
Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure
Apr 27, 2026
8-K
Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure
Apr 21, 2026
8-K
Other events
Apr 9, 2026
8-K
Results of operations (earnings release)
Apr 7, 2026
10-K
Fiscal year ended 2025-12-31
Apr 7, 2026
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation
Mar 9, 2026
8-K
Delisting notice or listing-rule failure
Mar 6, 2026
8-K
Amended charter or bylaws
Mar 3, 2026
8-K
Modified rights of security holders; Regulation FD disclosure; Other events
Feb 18, 2026
8-K
Entered a material agreement; Unregistered sale of equity
Jan 23, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Jan 15, 2026
8-K/A
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jan 12, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jan 12, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jan 12, 2026
8-K
Entered a material agreement; Unregistered sale of equity
Dec 12, 2025
8-K
Shareholder vote results; Regulation FD disclosure
Dec 8, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Nov 19, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Nov 14, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Unregistered sale of equity
Oct 3, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Oct 1, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws
Sep 11, 2025
8-K
Shareholder vote results; Regulation FD disclosure
Aug 19, 2025